ITRM920350A1 - Epitopi immunologicamente omologhi di hla e proteine del virus hiv. - Google Patents

Epitopi immunologicamente omologhi di hla e proteine del virus hiv.

Info

Publication number
ITRM920350A1
ITRM920350A1 IT000350A ITRM920350A ITRM920350A1 IT RM920350 A1 ITRM920350 A1 IT RM920350A1 IT 000350 A IT000350 A IT 000350A IT RM920350 A ITRM920350 A IT RM920350A IT RM920350 A1 ITRM920350 A1 IT RM920350A1
Authority
IT
Italy
Prior art keywords
epitopes
immunologically
hla
hiv virus
homological
Prior art date
Application number
IT000350A
Other languages
English (en)
Inventor
Alberto Beretta
Original Assignee
Fond Ct San Romanello Del Monte Tabor Or
Ist Superiore Sanita
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fond Ct San Romanello Del Monte Tabor Or, Ist Superiore Sanita filed Critical Fond Ct San Romanello Del Monte Tabor Or
Publication of ITRM920350A0 publication Critical patent/ITRM920350A0/it
Priority to ITRM920350A priority Critical patent/IT1254360B/it
Priority to PCT/IT1993/000049 priority patent/WO1993023427A1/en
Priority to EP93910325A priority patent/EP0641357B1/en
Priority to US08/335,733 priority patent/US6042831A/en
Priority to CA002135630A priority patent/CA2135630C/en
Priority to DE69327529T priority patent/DE69327529T2/de
Priority to AT93910325T priority patent/ATE188484T1/de
Publication of ITRM920350A1 publication Critical patent/ITRM920350A1/it
Application granted granted Critical
Publication of IT1254360B publication Critical patent/IT1254360B/it
Priority to US09/243,079 priority patent/US20020081566A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ITRM920350A 1992-05-11 1992-05-11 Epitopi immunologicamente omologhi di hla e proteine del virus hiv. IT1254360B (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
ITRM920350A IT1254360B (it) 1992-05-11 1992-05-11 Epitopi immunologicamente omologhi di hla e proteine del virus hiv.
CA002135630A CA2135630C (en) 1992-05-11 1993-05-10 Hiv protein epitopes immunologically homologous to hla
EP93910325A EP0641357B1 (en) 1992-05-11 1993-05-10 Hiv protein epitopes immunologically homologous to hla
US08/335,733 US6042831A (en) 1992-05-11 1993-05-10 Human immunodeficiency virus type 1 (HIV-1) GP160 epitopes that are immunologically homologous to epitopes located in the class I major histocompatibility complex (MHC) heavy chain α-1 domain
PCT/IT1993/000049 WO1993023427A1 (en) 1992-05-11 1993-05-10 Hiv protein epitopes immunologically homologous to hla
DE69327529T DE69327529T2 (de) 1992-05-11 1993-05-10 Immunologisch mit HLA homologe HIV Protein Epitope
AT93910325T ATE188484T1 (de) 1992-05-11 1993-05-10 Immunologisch mit hla homologe hiv protein epitope
US09/243,079 US20020081566A1 (en) 1992-05-11 1999-02-02 Hiv protein epitopes immunologically homologous to hla

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM920350A IT1254360B (it) 1992-05-11 1992-05-11 Epitopi immunologicamente omologhi di hla e proteine del virus hiv.

Publications (3)

Publication Number Publication Date
ITRM920350A0 ITRM920350A0 (it) 1992-05-11
ITRM920350A1 true ITRM920350A1 (it) 1993-11-11
IT1254360B IT1254360B (it) 1995-09-14

Family

ID=11400995

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM920350A IT1254360B (it) 1992-05-11 1992-05-11 Epitopi immunologicamente omologhi di hla e proteine del virus hiv.

Country Status (7)

Country Link
US (2) US6042831A (it)
EP (1) EP0641357B1 (it)
AT (1) ATE188484T1 (it)
CA (1) CA2135630C (it)
DE (1) DE69327529T2 (it)
IT (1) IT1254360B (it)
WO (1) WO1993023427A1 (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254360B (it) * 1992-05-11 1995-09-14 San Romanello Centro Fond Epitopi immunologicamente omologhi di hla e proteine del virus hiv.
IT1264078B1 (it) * 1993-09-10 1996-09-10 San Romanello Centro Fond Uso di anticorpi anti-molecole hla classe i libere da beta-2 microglobulina per saggi di evidenziazione dell'esposizione al virus
CN1339320A (zh) * 2000-08-18 2002-03-13 清华大学 一种艾滋病疫苗及其制备方法与应用
US7923209B2 (en) 2003-03-14 2011-04-12 Anergis, S.A. Allergen peptide fragments and use thereof
WO2011119920A2 (en) 2010-03-25 2011-09-29 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
ES2667425T3 (es) 2011-06-10 2018-05-10 Oregon Health & Science University Glucoproteínas y vectores recombinantes de CMV
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (en) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
WO2017152144A1 (en) * 2016-03-03 2017-09-08 Duke University Swarm immunization with envelopes from ch505

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943628A (en) * 1988-06-13 1990-07-24 Ortho Pharmaceutical Corporation HIV peptide-inducted T cell stimulation
HUT62316A (en) * 1990-09-25 1993-04-28 Hiver Ltd Process for producing aids vaccine and for diagnosing aids
JPH06501260A (ja) * 1990-09-27 1994-02-10 シンテロ　ヴァクシーン　ディベロップメント　ケービー ヒト免疫不全ウィルスに対する中和抗体の誘発とワクチン接種に用いられるペプチド
IT1254360B (it) * 1992-05-11 1995-09-14 San Romanello Centro Fond Epitopi immunologicamente omologhi di hla e proteine del virus hiv.

Also Published As

Publication number Publication date
WO1993023427A1 (en) 1993-11-25
US20020081566A1 (en) 2002-06-27
US6042831A (en) 2000-03-28
DE69327529D1 (de) 2000-02-10
ITRM920350A0 (it) 1992-05-11
ATE188484T1 (de) 2000-01-15
IT1254360B (it) 1995-09-14
CA2135630C (en) 2005-03-22
EP0641357B1 (en) 2000-01-05
DE69327529T2 (de) 2000-08-10
EP0641357A1 (en) 1995-03-08
CA2135630A1 (en) 1993-11-25

Similar Documents

Publication Publication Date Title
DK0527760T3 (da) Fremgangsmåder og præparater til vaccination mod HIV
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
ATE144143T1 (de) Künstlicher impfstoff gegen aids-virus
PE20040554A1 (es) Vacunas que comprenden proteinas de fusion
NO20000850L (no) Vaksine
IS4703A (is) Þáttur er örvar griplufrumur
ATE258188T1 (de) Retro-, inverso-, und retro-inverso synthetische peptidanaloge
HUP9802819A2 (hu) Hősokkfehérje-alapú oltóanyagok és immunterápiák
HUP9902438A2 (hu) Parapoxvírus vektorok
DE69327529D1 (de) Immunologisch mit HLA homologe HIV Protein Epitope
DE3751751D1 (de) Für das t-zell oberflächenprotein t4 kodierende dna und verwendung von t4-fragmenten bei der behandlung von aids
ATE295895T1 (de) Genetischer impfstoff gegen den immunschwäche virus
DK614987A (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
GB2255093A (en) Hiv-1 core protein fragments
DK0541692T3 (da) Herpes simplex virus VP-16-vacciner
DE3855134D1 (de) Monoklonale menschliche antikörper gegen hiv-i
DE69123970D1 (de) Ehv-4 glykoprotein vazin
ATE72400T1 (de) Kreuzreaktive und schuetzende epitope von circumsporozoit-proteinen.
NO175846C (no) Fremgangsmåte for å oppnå et immunogen
DE69433057D1 (de) Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus
DE69637435D1 (de) Saponin-zusammensetzungen und deren verwendung
ATE137674T1 (de) Von mca 16-88 erkanntes antigen
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов
SURCEL Human T lymphocyte responses to Francisella tularensis membrane components.
ATE122236T1 (de) Vorläufer des hüllenglykoproteins des hiv-2 retrovirus und verwandte antigene.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960419